Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

SentreHEART closes $35mm Series D

Executive Summary

SentreHEART Inc. (developed the Lariat device for left atrial appendage closure) raised $35mm through its Series D financing led by Deerfield Management, which adds a board member and was joined by returning shareholders US Venture Partners, Prospect Ventures, Vivo Capital, and Decheng Capital. The company will use the proceeds to complete a clinical trial of Lariat as an adjunctive treatment to ablation in patients with atrial fibrillation.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies